FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Award Details
- Contract Award Date: Sep 29, 2022
- Contract Award Number: Multiplenumbersseeattachment
- Task/Delivery Order Number:
- Contractor Awarded Unique Entity ID:
- Contractor Awarded Name: Georgia Tech Research Corp
- Contractor Awarded Address: Atlanta, GA 30332 USA
- Base and All Options Value (Total Contract Value): $202,527,229.11
General Information
- Contract Opportunity Type: Award Notice (Original)
- Original Published Date: Oct 12, 2022 01:17 pm EDT
- Inactive Policy: 15 days after contract award date
- Original Inactive Date: Oct 14, 2022
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: AJ11 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
- NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Place of Performance: , MD 20993USA
Description
This award notice is for all awards issued off the BAA and is not only an award to Georgia Tech Research Corp (system limitations required one entity identified). See attachment for a list of all awards.
Save the date for the 2022 FDA Broad Agency Announcement Day!
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. Join us to learn more about the FY 2023 BAA, and how to apply.
Stay tuned. We'll add more information to this page, including how to attend this virtual event, as it becomes available.
Link below:
https://www.fda.gov/science-research/fda-broad-agency-announcement-day-2022-12062022
Attachments/Links
Contact Information
Primary Point of Contact
- Kimberly DeLong
- kimberly.delong@fda.hhs.gov
Secondary Point of Contact
History
- Oct 14, 2022 11:56 pm EDTAward Notice (Original)
- Sep 30, 2022 11:56 pm EDTSolicitation (Updated)